Moneycontrol
HomeNewsBusinessMutual FundsCoronavirus impact: Mutual fund houses to work 'as normal' till March 31
Trending Topics

Coronavirus impact: Mutual fund houses to work 'as normal' till March 31

Many asset management companies have asked their employees to work on a rotational basis to ensure their safety and smooth functioning of operations

March 22, 2020 / 14:12 IST
Story continues below Advertisement

The mutual fund industry will continue to function, even though the Maharashtra government announced a complete lockdown on private offices till March 31 in the wake of the fast-spreading novel coronavirus.

A fund official said, “Since stock exchanges will continue to function as normal so all SEBI-registered companies such as mutual funds will remain open. So, financial services have been exempted from this rule.”

Story continues below Advertisement

Many asset management companies have asked their employees to work on a rotational basis to ensure their safety and smooth functioning of mutual fund operations

“We have asked employees to come on alternate weeks. One lot comes one week then the office gets completely sanitised and the next week other lot comes in,” said a spokesperson from Franklin Templeton Mutual Fund.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show